InvestorsHub Logo
Followers 131
Posts 11471
Boards Moderated 0
Alias Born 01/06/2010

Re: None

Friday, 10/13/2017 9:42:21 AM

Friday, October 13, 2017 9:42:21 AM

Post# of 1085
BRIEF-Resverlogix reports $87 mln private placement with Shenzhen Hepalink
REUTERS 8:35 AM ET 10/13/2017
Symbol Last Price Change
RVXCF 1.4184up 0 (0%)
QUOTES AS OF 02:52:01 PM ET 10/12/2017
Oct 13 (Reuters) - Resverlogix Corp(RVXCF):

* Resverlogix(RVXCF) announces $87 million private placement with shenzhen hepalink

* Resverlogix Corp(RVXCF) - ?net proceeds of offering will primarily be used to repay company's $68.8 million secured loan which matures on December 26, 2017?

* Resverlogix Corp(RVXCF) - ? private placement of 60.4 million equity units to Shenzhen Hepalink Pharmaceutical Co. Ltd. At a price of $1.44 per unit?

* Resverlogix-Proceeds will also be used to fund research,development activities for clinical trial activities related to phase 3 betonmace trial?

* Resverlogix(RVXCF) - ? placement to address co's financial difficulties by providing sufficient funds to repay loan and to satisfy short term cash requirements? Source text for Eikon: Further company coverage: